“말레이시아”的搜索结果，显示 191-200 项，共有 15995 项

1. 血液科- 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   To determine the maximally tolerated dose (MTD) of intratumoral administration of an Edmonston strain measeles virus genetically engineered to express NAP ...

3. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop and maintain a registry of clinical data and biological specimens from patients with immune system related blood ...

4. 血液科- 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

5. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

6. 将您的个人和家庭健康记录存放在方便随手取用的地方

   应急准备包括确保您可以快速访问自己和家人的重要健康信息。

7. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

8. 血液科- 临床试验- 妙佑医疗国际

   This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

9. 神经科- 临床试验- 妙佑医疗国际

   99 研究神经科（仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 Peripheral Nerve Stimulation Therapy for Atrial Fibrillation. Rochester, ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...